Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi

Stefano Luminari, Sara Galimberti, Annibale Versari, I. Biasoli, Antonella Anastasia, Chiara Rusconi, Angela Ferrari, Mario Petrini, Martina Manni, Massimo Federico

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)e66-e68
JournalHaematologica
Volume101
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Keywords

  • FDG-PET
  • Follicular lymphoma
  • Minimal residual disease
  • Nuclear medicine
  • Progression-free survival

ASJC Scopus subject areas

  • Hematology

Cite this

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi. / Luminari, Stefano; Galimberti, Sara; Versari, Annibale; Biasoli, I.; Anastasia, Antonella; Rusconi, Chiara; Ferrari, Angela; Petrini, Mario; Manni, Martina; Federico, Massimo.

In: Haematologica, Vol. 101, No. 2, 01.02.2016, p. e66-e68.

Research output: Contribution to journalArticle

Luminari, Stefano ; Galimberti, Sara ; Versari, Annibale ; Biasoli, I. ; Anastasia, Antonella ; Rusconi, Chiara ; Ferrari, Angela ; Petrini, Mario ; Manni, Martina ; Federico, Massimo. / Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi. In: Haematologica. 2016 ; Vol. 101, No. 2. pp. e66-e68.
@article{23505b20dec14c2091ebe84cf29bdb88,
title = "Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi",
keywords = "FDG-PET, Follicular lymphoma, Minimal residual disease, Nuclear medicine, Progression-free survival",
author = "Stefano Luminari and Sara Galimberti and Annibale Versari and I. Biasoli and Antonella Anastasia and Chiara Rusconi and Angela Ferrari and Mario Petrini and Martina Manni and Massimo Federico",
year = "2016",
month = "2",
day = "1",
doi = "10.3324/haematol.2015.132811",
language = "English",
volume = "101",
pages = "e66--e68",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi

AU - Luminari, Stefano

AU - Galimberti, Sara

AU - Versari, Annibale

AU - Biasoli, I.

AU - Anastasia, Antonella

AU - Rusconi, Chiara

AU - Ferrari, Angela

AU - Petrini, Mario

AU - Manni, Martina

AU - Federico, Massimo

PY - 2016/2/1

Y1 - 2016/2/1

KW - FDG-PET

KW - Follicular lymphoma

KW - Minimal residual disease

KW - Nuclear medicine

KW - Progression-free survival

UR - http://www.scopus.com/inward/record.url?scp=84957693140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957693140&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.132811

DO - 10.3324/haematol.2015.132811

M3 - Article

VL - 101

SP - e66-e68

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -